The effect of the Happi Liver mobile health application on the reduction of non-alcoholic fatty liver disease

The effect of the Happi Liver mobile health application on the reduction of non-alcoholic fatty liver disease - THETA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON52163

Enrollment

200

Registered

2022-02-17

Start date

2022-03-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver non-alcoholic fatty liver disease

Interventions

The intervention in the app group consists of asking people to use this application during their follow-up time.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Aged 18 years or older • Diagnosed with NAFLD by CAPTM (>215 dB/m) as measured by the FibroScan® device and VCTE

Exclusion criteria

Exclusion criteria: • Not proficient in the Dutch language • Already in a weight-loss/management project included (e.g., weight watchers, dietitian guidance).

Design outcomes

Primary

Measure	Time frame
Main study parameter/endpoint: a *5% reduction in weight measured in kg.	—

Secondary

Measure	Time frame
Secondary study parameters/endpoints: 1) Reduction of NAFLD (as measured by the FibroScan®). 2) Acceptability and satisfaction of the Happi liver mobile application. 3) An increase in knowledge concerning NAFLD. 4) Quality of life improvement.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)